Status:

RECRUITING

Long Term Outcome of Easophageal Atresia : Transmics Profiles in Adolescence

Lead Sponsor:

University Hospital, Lille

Collaborating Sponsors:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

Esophageal Atresia

Eligibility:

All Genders

13-14 years

Brief Summary

Oesophageal atresia (OAEA), a malformation of the oesophagus present from birth, is characterized by the interruption of the continuity of the oesophagus, which then ends in a cul-de-sac. (Source: Fim...

Eligibility Criteria

Inclusion

  • For the oesophageal atresia group :
  • Born with oesophageal atresia (EA) in France or in French overseas departments and territories
  • Anastomosis performed
  • Included into the ReNaTo registry
  • Aged 13 or 14 during the recruitment period
  • Patient willing to comply with all study procedures and duration
  • Patient will social security
  • For the blood sub-study :
  • Upper GI endoscopy performed as part of care between 13 and 14 years of age with esophageal mucosal biopsy sampling
  • Patient having given written consent to participate in the study
  • For the control arm:
  • Upper GI endoscopy performed as part of care between 10 and 14 years of age with oesophageal mucosal biopsy sampling
  • Upper GI endoscopy performed as part of care for chronic or acute digestive signs to rule out organic etiology (peptic esophagitis, gastric esophagitis, eosinophilic esophagitis or ulcer)
  • Normal endoscopy and histology
  • No chronic progressive disease

Exclusion

  • For the oesophagal atresia arm :
  • Concurrent participation in an interventional trial and in the 3 months prior to inclusion
  • Parents refusing to participate in the study
  • For the control arm :
  • Histologically non-normal esophageal biopsy
  • Parents refusing to participate in the study
  • Child with known organic pathology

Key Trial Info

Start Date :

November 14 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

November 14 2026

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT05995171

Start Date

November 14 2023

End Date

November 14 2026

Last Update

September 26 2024

Active Locations (33)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (33 locations)

1

CHU de Lille Hôpital Jeanne de Flandre

Lille, Nord, France, 59000

2

CHU Amiens

Amiens, France

3

CHU Angers

Angers, France

4

CHU Besançon

Besançon, France